Cargando…

Construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: A validation study

AIM: This study aims to construct a new staging system for colorectal cancer (CRC) based on the lymph node ratio (LNR) as a supplement to the American Joint Committee on Cancer (AJCC) tumor node metastasis (TNM) staging system for predicting the prognosis of CRC patients with <12 lymph nodes. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yan, Wang, Yawei, Wang, Zhengbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452833/
https://www.ncbi.nlm.nih.gov/pubmed/36090338
http://dx.doi.org/10.3389/fsurg.2022.929576
_version_ 1784785002483941376
author Yang, Yan
Wang, Yawei
Wang, Zhengbin
author_facet Yang, Yan
Wang, Yawei
Wang, Zhengbin
author_sort Yang, Yan
collection PubMed
description AIM: This study aims to construct a new staging system for colorectal cancer (CRC) based on the lymph node ratio (LNR) as a supplement to the American Joint Committee on Cancer (AJCC) tumor node metastasis (TNM) staging system for predicting the prognosis of CRC patients with <12 lymph nodes. METHODS: The data of 26,695 CRC patients with <12 lymph nodes were extracted from the Surveillance, Epidemiology, and End Results (SEER) database as a training set. A total of 635 CRC patients were also enrolled from Northern Jiangsu People's Hospital affiliated with Yangzhou University as an independent validation set. Classification and regression tree analysis was used to obtain the LNR cutoff value. Survival curves were estimated using the Kaplan–Meier method, and the log-rank test was used for comparisons of differences among the survival curves. The monotonic decreasing trend of the overall survival curve in the staging system was expressed by the linear correlation degree R. RESULTS: The 5-year survival rates of patients in the training set based on the AJCC staging system from stage I to stage IV were 75.6% (95%CI: 74.4–76.8), 59.8% (95%CI: 58.6–61.0), 42.1% (95%CI: 34.5–49.7), 33.2% (95%CI: 24.6–41.8), 72.0% (95%CI: 69.1–74.9), 48.8% (95%CI: 47.4–50.2), 26.5% (95%CI: 23.0–30.0), and 11.3% (95%CI: 10.3–12.3). The 5-year survival rates of patients in the training set from stage I to stage IIIC were 80.4%, 72.9%, 59.8%, 48.4%, 32.5%, and 15.0%, according to the TNM + LNR (TNRM) staging system. According to the AJCC staging system, the 5-year survival rates of patients in the validation set from stage I to stage IIIC were 91.3%, 90.8%, 72.6%, 61.3%, 72.4%, 58.1%, and 32.8%. Based on the TNRM staging system, the 5-year survival rates of patients in the validation set from stage I to stage IIIC were 99.2%, 90.5%, 81.4%, 78.6%, 60.2%, and 35.8%. CONCLUSION: The TNRM staging system successfully eliminated “survival paradox” in the AJCC staging system, which might be superior to the AJCC staging system.
format Online
Article
Text
id pubmed-9452833
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94528332022-09-09 Construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: A validation study Yang, Yan Wang, Yawei Wang, Zhengbin Front Surg Surgery AIM: This study aims to construct a new staging system for colorectal cancer (CRC) based on the lymph node ratio (LNR) as a supplement to the American Joint Committee on Cancer (AJCC) tumor node metastasis (TNM) staging system for predicting the prognosis of CRC patients with <12 lymph nodes. METHODS: The data of 26,695 CRC patients with <12 lymph nodes were extracted from the Surveillance, Epidemiology, and End Results (SEER) database as a training set. A total of 635 CRC patients were also enrolled from Northern Jiangsu People's Hospital affiliated with Yangzhou University as an independent validation set. Classification and regression tree analysis was used to obtain the LNR cutoff value. Survival curves were estimated using the Kaplan–Meier method, and the log-rank test was used for comparisons of differences among the survival curves. The monotonic decreasing trend of the overall survival curve in the staging system was expressed by the linear correlation degree R. RESULTS: The 5-year survival rates of patients in the training set based on the AJCC staging system from stage I to stage IV were 75.6% (95%CI: 74.4–76.8), 59.8% (95%CI: 58.6–61.0), 42.1% (95%CI: 34.5–49.7), 33.2% (95%CI: 24.6–41.8), 72.0% (95%CI: 69.1–74.9), 48.8% (95%CI: 47.4–50.2), 26.5% (95%CI: 23.0–30.0), and 11.3% (95%CI: 10.3–12.3). The 5-year survival rates of patients in the training set from stage I to stage IIIC were 80.4%, 72.9%, 59.8%, 48.4%, 32.5%, and 15.0%, according to the TNM + LNR (TNRM) staging system. According to the AJCC staging system, the 5-year survival rates of patients in the validation set from stage I to stage IIIC were 91.3%, 90.8%, 72.6%, 61.3%, 72.4%, 58.1%, and 32.8%. Based on the TNRM staging system, the 5-year survival rates of patients in the validation set from stage I to stage IIIC were 99.2%, 90.5%, 81.4%, 78.6%, 60.2%, and 35.8%. CONCLUSION: The TNRM staging system successfully eliminated “survival paradox” in the AJCC staging system, which might be superior to the AJCC staging system. Frontiers Media S.A. 2022-08-25 /pmc/articles/PMC9452833/ /pubmed/36090338 http://dx.doi.org/10.3389/fsurg.2022.929576 Text en © 2022 Yang, Wang and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Yang, Yan
Wang, Yawei
Wang, Zhengbin
Construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: A validation study
title Construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: A validation study
title_full Construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: A validation study
title_fullStr Construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: A validation study
title_full_unstemmed Construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: A validation study
title_short Construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: A validation study
title_sort construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: a validation study
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452833/
https://www.ncbi.nlm.nih.gov/pubmed/36090338
http://dx.doi.org/10.3389/fsurg.2022.929576
work_keys_str_mv AT yangyan constructionofanewclinicalstagingsystemforcolorectalcancerbasedonthelymphnoderatioavalidationstudy
AT wangyawei constructionofanewclinicalstagingsystemforcolorectalcancerbasedonthelymphnoderatioavalidationstudy
AT wangzhengbin constructionofanewclinicalstagingsystemforcolorectalcancerbasedonthelymphnoderatioavalidationstudy